Proposal to widen access to nivolumab and ipilimumab for resectable melanoma

Pharmac is seeking feedback on a proposal to widen access to nivolumab and ipilimumab for people with stage 3B to stage 4 melanoma that can be removed with surgery.

If approved, funded access to these medicines would be widened from 1 May 2026.

For more information on this consultation, read the full proposal to widen access to nivolumab and ipilimumab for resectable melanoma

We welcome your feedback. Consultation is open until 5pm Monday 9 March 2026. Please send your feedback to consult@pharmac.govt.nz.

Ngā mihi

___________________________________________________________________

Pharmac | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington

P: 0800 660 050 | www.pharmac.govt.nz